Travellers vaccinated with Covishield, manufactured by Pune-based Serum Institute of India (SII), may not be eligible for the European Union ‘Green Pass’, being launched to enable easy travel into and between EU countries.
The digital “vaccine passport” recognises the Vaxzevria version of the AstraZeneca NSE -0.22 % vaccine that is produced in the UK and Europe, and approved by the European Medicines Agency (EMA). Covishield, manufactured by the Serum Institute of India, is not yet recognised by the EMA.
The EMA, which is the agency of the European Union responsible for the evaluation and supervision of medicinal products, has approved only four Covid-19 vaccines so far: Comirnaty (BioNTech-Pfizer), Moderna, Vaxzevria (Oxford-AstraZeneca) and Janssen (Johnson & Johnson). EU member states that issue the Green Pass must accept these four vaccines, but are free to accept others as well.
An email sent to EMA and SII did not elicit any response.
Read more at: https://economictimes.indiatimes.com/news/india/no-european-union-green-pass-for-covishield-yet/articleshow/83886024.cms
Comments